Dublin, Nov. 6, 2013 (GLOBE NEWSWIRE) -- Global Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA Delivery) Technologies Market (2012 - 2017)
Research and Markets (http://www.researchandmarkets.com/research/f472jd/global)
has announced the addition of the "Global
Transfection (Gene Delivery, DNA Delivery, Protein Delivery, SiRNA
Delivery) Technologies (Lipofection, Calcium Phosphate,
Electroporation, Nucleofection, Magnetofection, Gene Gun, Viral)
Market (2012 - 2017)" report to their offering.
Transfection is an enabler technology used for many cell based
research activities with applications spanning production of
recombinant proteins and recombinant cell lines, gene therapy,
delivery of therapeutics and also drug discovery. This research
report provides a brief description on transfection technologies,
its evolution, comparative analysis, market landscape analysis,
competitive scenario and emerging technology and application
trends. Global research and development Network, Innovation and
Spin offs have been discussed. The report tracks regional adoption
and development trends, providing strategic recommendation to stay
active and compete in the market space. An impact analysis of major
drivers and restraints influencing the growth of the market is
mapped for five year period.
Key Driver:
Advances in cell research and therapeutic delivery
Cell research is a major driving factor for transfection market, as
more than 60% of the users are of academic institutions and
researchers. Research in gene transfer is being performed in in
vivo conditions for different therapeutic applications; there is a
growing demand for new transfection technologies to address unmet
needs for therapeutic delivery which is driving the transfection
market.
Key Restraint:
Home brew Reagents restricts sale of commercial kits
Home brew reagents are still the preferred choice of reagents for
transfection
by researchers all over the world. Most of the researchers prepare
their own reagents from their laboratory to conduct their research.
This is true for most of the reagent based transfection reactions.
This allows them to reduce cost involved in purchasing commercial
kits.
Key Challenge:
New disruptive technologies required to address transfection in
hard-to-transfect cells
Transfection is an enabler technology which is used in many cell
research activities, however only few cell lines are majorly used
in these experiments restricting the scope of the study.
Transfection in hard to transfect cells is the need of hour and it
is a major challenge. There are few upcoming transfection
technologies like nucleofection and magnetofection - which are an
off-shoot of electroporation, which have the potential to address
these challenges but are currently cost prohibitive due to which
the technologies may have a much slower uptake in the developing
world.
Key Topics Covered:
1. Introduction
2. Executive Summary
3. Transfection Technologies - Technology Landscape Analysis
4. Transfection - Market Landscape Analysis
5. Global R&D Portfolio Analysis
6. Investment/Funding Analysis
7. Transfection - Diffusion Analysis
8. Competitive Landscape
9. Opportunity Evaluation And Technology
Benchmarking/Roadmapping
10. Patent Analysis
11. Analyst Insights And Recommendations
12. Company Profiles
Companies Mentioned
- Altogen Biosystems
- Bio-Rad Laboratories Inc.
- Clonetech Laboratories, Inc.
- Deliverics Ltd.
- Genlantis
- Inovio Pharmaceuticals Inc.,
- Life Technologies Corporation
- Lonza Group Ltd.
- Maxcyte, Inc.
- Mirus Bio Llc.
- Molecular Transfer Inc.,
- Nanotherics
- Oz Biosciences
- Polyplus Transfection S.A.
- Promokine Gmbh
- Promega Corporation
- Qiagen N.V.
- Roche Applied Science
- Signagen Laboratories
- Sigma Aldrich Corporation
- Thermo Fisher Scientific Inc.
- Techulon Inc.,
For more information visit http://www.researchandmarkets.com/research/f472jd/global
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Biotechnology